StockData
CNS Pharmaceuticals, Inc. logo

CNS Pharmaceuticals, Inc. (CNSP) KPIs and segments

CNSPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$3.48+0.59 (+20.42%)

Close on Nov 16, 2026Market cap $5.09MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive CNS Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to CNS Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?